An individual has been fined three times totalling $7,992 (US$5,710) by Australia’s drug regulatory body for allegedly advertising ivermectin and zinc lozenges to treat COVID-19. The Therapeutic Goods Administration (TGA) has previously warned consumers and advertisers about illegally promoting ivermectin in relation to COVID-19. “The individual allegedly claimed, on their website, that ivermectin and zinc lozenges are effective in the treatment of COVID-19,” the TGA said in a press release on Nov. 30. “References in advertising to the coronavirus (COVID-19) are a restricted representation and the individual had not been granted authorisation to make the claim.” The TGA said the individual claimed on their website that ivermectin was “safe” to use for COVID-19. The regulatory body has taken a tough stance on “false and misleading” advertising around products related to COVID-19. “If you are suspicious of the claims being made about a product, including those advertised as preventing or curing …